Achyut Healthcare Limited (BOM:543499)
7.00
0.00 (0.00%)
At close: Aug 24, 2026
Achyut Healthcare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,689 | 1,272 | 768 | 875 | 511 | 139 | |
Market Cap Growth | 39.00% | 65.64% | -12.21% | 71.19% | 268.87% | - |
Enterprise Value | 1,671 | 1,203 | 760 | 873 | 448 | 91 |
Last Close Price | 7.00 | 5.27 | 3.26 | 3.71 | 2.60 | 0.98 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 467.75 | 402.90 | 140.21 | 174.15 | 221.01 | 343.74 |
PS Ratio | 14.53 | 10.97 | 25.20 | 14.25 | 18.96 | 3.42 |
PB Ratio | 4.82 | 3.63 | 2.45 | 2.85 | 3.52 | 1.53 |
P/TBV Ratio | 4.82 | 3.63 | 2.45 | 2.85 | 3.52 | 1.53 |
P/OCF Ratio | 148.92 | 112.12 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 14.37 | 10.38 | 24.93 | 14.23 | 16.61 | 2.26 |
EV/EBITDA Ratio | - | 694.32 | - | 1666.87 | - | - |
EV/EBIT Ratio | - | 3418.33 | - | 1989.61 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.04 | 0.04 | - | - | - | - |
Debt / EBITDA Ratio | 4.64 | 8.58 | - | - | - | - |
Net Debt / Equity Ratio | -0.05 | -0.05 | -0.22 | -0.68 | -0.60 | -0.61 |
Net Debt / EBITDA Ratio | -5.62 | -10.39 | 34.37 | -398.71 | 33.53 | 166.51 |
Net Debt / FCF Ratio | - | 0.25 | 0.46 | 3.28 | 2.32 | 0.80 |
Asset Turnover | - | 0.33 | 0.10 | 0.27 | 0.21 | 0.78 |
Inventory Turnover | - | 32.12 | 23.66 | 29.61 | 8.84 | 29.81 |
Quick Ratio | - | 2.75 | 6.35 | 105.80 | 11.01 | 6.83 |
Current Ratio | - | 4.59 | 9.32 | 106.59 | 12.68 | 9.13 |
Return on Equity (ROE) | - | 0.95% | 1.76% | 2.22% | 1.96% | 0.86% |
Return on Assets (ROA) | - | 0.06% | -0.42% | 0.12% | -1.31% | -0.46% |
Return on Invested Capital (ROIC) | 0.36% | 0.10% | -0.98% | 0.38% | -4.24% | -0.83% |
Return on Capital Employed (ROCE) | - | 0.10% | -0.70% | 0.10% | -1.80% | -0.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.21% | 0.25% | 0.71% | 0.57% | 0.45% | 0.29% |
FCF Yield | -4.23% | -5.61% | -19.44% | -7.28% | -7.33% | -50.45% |
Buyback Yield / Dilution | -0.49% | -0.02% | -1.37% | -18.41% | -38.63% | -1319.16% |